Smart insulin pump beats daily shots in diabetes trial
NCT ID NCT05923827
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether the Omnipod 5, a tubeless automated insulin pump, works better than multiple daily insulin injections for managing type 1 diabetes. 189 children and adults participated. The main goal was to see if the pump improved blood sugar control (HbA1c) over 13 weeks. The pump automatically adjusts insulin based on continuous glucose monitor readings, aiming for steadier blood sugar levels.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Omnipod 5 System (automated insulin pump)
What this could lead to
If successful, this could provide a more convenient and effective way to manage type 1 diabetes, reducing the burden of multiple daily injections and improving blood sugar levels.
What could go wrong
This is a completed trial, but results may not apply to everyone. The device requires proper use and monitoring, and there is always a risk of pump malfunction or skin reactions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 1 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Grenoble Aples
Grenoble, France
-
CHU Rennes
Rennes, France
-
CHU Toulouse
Toulouse, France
-
CHU de Nancy
Nancy, France
-
Centre Hospitalier Universitaire Carémeau de Nîmes
Nîmes, France
-
Centre Hospitalier Universitaire Côte de Nacre
Caen, France
-
Centre Hospitalier Universitaire de Reims
Reims, France
-
Cliniques Universitaires Saint-Luc
Brussels, Belgium
-
Hospices Civils de Lyon
Lyon, France
-
Hôpital Necker
Paris, France
-
Hôpitaux Pédiatriques de Nice CHU-Lenval,
Nice, France
-
Hôpitaux Universitaires de Marseille Timone
Marseille, France
-
Manchester University NHS Foundation Trust
Manchester, United Kingdom
-
Mersey and West Lancashire NHS Teaching Hospitals Trust
Ormskirk, United Kingdom
-
Oxford Health NHS Foundation Trust
Oxford, United Kingdom
-
Robert-Debré AP-HP Hospital
Paris, France
-
Universitaire Ziekenhuizen Leuven
Leuven, Belgium
-
University Hospitals of Derby & Burton
Derby, United Kingdom
-
University Hospitals of Leicester NHS Trust
Leicester, United Kingdom